Buprenorphine Transdermal Patch and Ranibizumab Intraocular
Determining the interaction of Buprenorphine Transdermal Patch and Ranibizumab Intraocular and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: buprenorphine
Brand name: Probuphine, Belbuca, Buprenex, Butrans, Sublocade, Subutex
Synonyms: Buprenorphine (implant), Buprenorphine
Generic Name: ranibizumab ophthalmic
Brand name: Lucentis
Synonyms: Ranibizumab (ophthalmic), Ranibizumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Buprenorphine Transdermal Patch-Ranibizumab ophthalmic
- Buprenorphine Transdermal Patch-Ranitidine
- Buprenorphine Transdermal Patch-Ranitidine Capsule
- Buprenorphine Transdermal Patch-Ranitidine Hydrochloride
- Buprenorphine Transdermal Patch-Ranitidine Injection
- Buprenorphine Transdermal Patch-Ranitidine Suspension
- Ranibizumab Intraocular-Buprenorphine transdermal skin patch
- Ranibizumab Intraocular-Buprenorphine, Buprenorphine Hydrochloride
- Ranibizumab Intraocular-Buprenorphine/naloxone Oromucosal, Sublingual
- Ranibizumab Intraocular-Buproban
- Ranibizumab Intraocular-Bupropion
- Ranibizumab Intraocular-Bupropion and naltrexone